Try our Advanced Search for more refined results
April 19, 2021
In Re Emergent Biosolutions Inc. Securities Litigation
Case Number:
8:21-cv-00955
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Arnold & Porter
- Brown Goldstein
- Cohen Milstein
- Goldman & Minton
- Keller Postman
- Miles & Stockbridge
- Miller & Chevalier
- Murphy Anderson PLLC
- Murphy Falcon
- Pomerantz LLP
- Saxena White
- Silverman Thompson
- WilmerHale
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 05, 2023
Emergent Gets Investor Suit Over COVID Vaccine Trimmed
A Maryland federal judge trimmed a consolidated class action claiming that Emergent BioSolutions Inc. misled investors about how prepared it was to handle two high-profile deals to manufacture COVID-19 vaccines, ruling that the investors' fraud claims relating to past earning statements and internal controls can be dismissed.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login